Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI2 | P48307 | 6/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | PPP5C | P53041 | 3/20 | 0.47 |
| ▸ | PPM1B | O75688 | 3/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | PPP1CC | P36873 | 2/20 | 0.41 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.37 |
| ▸ | PPP2CA | P67775 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7350140 | 0.88 | TFPI2 (0.47) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL27831580 | 0.86 | TFPI2 (0.43) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL28136773 | 0.84 | — | — | |
| SCHEMBL21647281 | 0.78 | TP53 (0.54) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL6212412 | 0.77 | PPP5C (0.46) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL1963237 | 0.75 | GABRR1 (0.50) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL722221 | 0.75 | GABRR1 (0.50) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL9782998 | 0.75 | GABRR1 (0.50) | TFPI2LMNATSHRKDM4EGMNN | |
| SCHEMBL21436920 | 0.72 | PPM1B (0.53) | PPM1BPTPN1PPP1CC | |
| SCHEMBL11146792 | 0.71 | PEPD (0.41) | TFPI2LMNATSHRKDM4EGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 986 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250140858-A1 | CATHODE COATING FOR LI-ION BATTERY | ARKEMA FRANCE (FR) | 2025-05-01 | — | — | US | claimed |
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| US-20240387886-A1 | ANODE COATING FOR ALL-SOLID-STATE LI-ION BATTERY | ARKEMA FRANCE (FR) | 2024-11-21 | — | — | US | claimed |
| CN-118382371-A | Articles containing melt-processible cellulose acetate compositions containing alkaline fillers | 伊士曼化工公司 | 2024-07-23 | — | — | CN | claimed |
| CN-117679381-A | Dipyridamole osmotic pump controlled release tablet and preparation method thereof | 九华华源药业(桂林)有限公司 | 2024-03-12 | — | — | CN | claimed |
| US-20230355483-A1 | TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION | L'OREAL (FR) | 2023-11-09 | — | — | US | claimed |
| EP-4216904-A1 | TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION | L'OREAL (FR) | 2023-08-02 | — | — | EP | claimed |
| US-20230174746-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-06-08 | — | — | US | claimed |
| CN-113398773-B | Poly (4-methyl-1-pentene) hollow fiber alloy membrane and preparation method and application thereof | 清华大学 | 2022-10-14 | — | — | CN | claimed |
| CN-109661615-B | Solution, solution container, actinic ray-sensitive or radiation-sensitive resin composition, pattern forming method, and method for manufacturing semiconductor device | 富士胶片株式会社 | 2022-08-02 | — | — | CN | claimed |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | L'OREAL S.A. (FR) | 2004-11-25 | — | — | US | claimed |
| US-20040175424-A1 | Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same | FLAMEL TECHNOLOGIES (FR) | 2004-09-09 | — | — | US | claimed |
| EP-0959685-B1 | EDIBLE MOLDED BODIES, ESPECIALLY FLAT AND FLEXIBLE TUBULAR FILMS | KALLE NALO GMBH & CO KG (DE) | 2003-03-26 | — | — | EP | claimed |
| EP-1137704-A4 | PRESSURE-SENSITIVE REMOVABLE ADHESIVES BASED ON POLYACRYLATES, PREPARATION PROCESS AND ARTICLES CONTAINING THEM | ATO FINDLEY INC (US) | 2002-11-04 | — | — | EP | claimed |
| EP-1181983-A2 | Spray gun for enteric coating and process for producing enteric coated preparation | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-02-27 | — | — | EP | claimed |
| EP-0894490-B1 | Cosmetic compositions comprising a film-forming polymer | OREAL (FR) | 2002-01-16 | — | — | EP | claimed |
| EP-1137704-A1 | PRESSURE-SENSITIVE REMOVABLE ADHESIVES BASED ON POLYACRYLATES, PREPARATION PROCESS AND ARTICLES CONTAINING THEM | Ato Findley Inc (US) | 2001-10-04 | — | — | EP | claimed |
| US-6110447-A | MIXTURES WITH SULFONAMIDES | L'OREAL (FR) | 2000-08-29 | — | — | US | claimed |
| WO-2000005299-A1 | PRESSURE-SENSITIVE REMOVABLE ADHESIVES BASED ON POLYACRYLATES, PREPARATION PROCESS AND ARTICLES CONTAINING THEM | ATO FINDLEY, INC. (US) | 2000-02-03 | — | — | WO | claimed |
| US-5753156-A | Process for producing non-scattering hollow plastic balloons | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 1998-05-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355483-A1 | TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION | POLG, FFAR2, POLA1 | TFPI2 4424/4885LMNA 3416/4885TSHR 4108/4885 |
| US-20040234612-A1 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one compound plasticizing the polymer | CUTA, AUP1, PLIN3 | TFPI2 2511/4885LMNA 457/4885TSHR 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.